Southpoint Capital Advisors LP Tango Therapeutics, Inc. Transaction History
Southpoint Capital Advisors LP
- $3.57 Billion
- Q3 2024
A detailed history of Southpoint Capital Advisors LP transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Southpoint Capital Advisors LP holds 5,000,000 shares of TNGX stock, worth $15.5 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 5,276,699
5.24%
Holding current value
$15.5 Million
Previous $45.3 Million
14.96%
% of portfolio
1.08%
Previous 1.32%
Shares
5 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
91.7MCall Options Held
3.1KPut Options Held
1.5K-
Trv Gp Iv, LLC Boston, MA16.9MShares$52.3 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$41.3 Million4.45% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$25.4 Million3.35% of portfolio
-
Nextech Invest Ag5.53MShares$17.2 Million6.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.02MShares$15.6 Million0.02% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $273M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...